InsidersTradesSigma
Discover the detailed record of transactions filed by LEFKOWITZ ROBERT J MD, Director. Officer active across 1 companies, notably Lexicon Pharmaceuticals, INC.. Cumulatively, 1 disclosures have been recorded. The latest transaction was filed on 30 April 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Robert J. Lefkowitz, MD, is a Board Member at Lexicon Pharmaceuticals, Inc. He brings medical and scientific expertise to the board, contributing to informed decision-making regarding product development and research strategies.